Internal Medicine, Gastroenterology · Woodland Hills, CA
NPI
1023166816
Since 2007
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
5601 de Soto Ave
Woodland Hills, CA, 91367
Phone (818) 719-2000
Groups this clinician bills Medicare through
Medicare paid, 2023
$983
13 services
Medicare patients, 2023
11
Average age 67
Drug cost, 2024
$405K
1,106 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Mark T Ewing prescribed most often to Medicare patients was Gavilyte-C (Peg3350/Sod Sulf,bicarb,cl/Kcl), with 311 prescriptions and refills. In total Mark T Ewing wrote 1,106 Medicare prescriptions that cost $405K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-11-30.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Gavilyte-C Peg3350/Sod Sulf,bicarb,cl/Kcl | 311 | 311 | 290 | $7,015 |
| Omeprazole Generic | 140 | 343 | 61 | $1,234 |
| Mesalamine Generic | 121 | 310 | 37 | $40K |
| Pantoprazole Sodium Generic | 76 | 187 | 29 | $924 |
| Trulance Plecanatide | 51 | 79 | 18 | $34K |
| Ursodiol Generic | 33 | 92 | Under 11 | $6,635 |
| Zenpep Lipase/Protease/Amylase | 25 | 52 | 11 | $48K |
| Pentasa Mesalamine | 22 | 50 | Under 11 | $41K |
| Azathioprine Generic | 20 | 63 | Under 11 | $1,110 |
| Ondansetron Odt Ondansetron | 20 | 20 | Under 11 | $173 |
| Famotidine Generic | 19 | 48 | Under 11 | $240 |
| Budesonide Dr Budesonide | 18 | 27 | Under 11 | $1,272 |
| Xifaxan Rifaximin | 15 | 15 | Under 11 | $45K |
| Metronidazole Generic | 15 | 15 | 11 | $139 |
| Budesonide Er Budesonide | 13 | 13 | Under 11 | $6,293 |
Brand drugs: 188 claims; generic drugs: 918 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Mark T Ewing were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.